Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca AbfiledCriticalAstrazeneca Ab
Priority to UY28406ApriorityCriticalpatent/UY28406A1/en
Publication of UY28406A1publicationCriticalpatent/UY28406A1/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
Compuestos de fórmula I: y sales farmacéuticamente aceptables de los mismos, en donde Q, Ar1, A y Ar2 son como definen en la memoria descriptiva, composiciones farmacéuticas y formulaciones que los contienen, métodos para utilizarlos para tratar enfermedades solos o en combinación con otros compuestos o sustancias terapéuticamente activos, procesos y compuestos intermedios utilizados para prepararlos, sus usos como medicamentos para terapia, sus usos en la fabricación de medicamentos y sus usos para fines de diagnóstico y análisis.Compounds of formula I: and pharmaceutically acceptable salts thereof, wherein Q, Ar1, A and Ar2 are as defined in the specification, pharmaceutical compositions and formulations containing them, methods for using them to treat diseases alone or in combination with others. therapeutically active compounds or substances, processes and intermediate compounds used to prepare them, their uses as drugs for therapy, their uses in the manufacture of medicines and their uses for diagnostic and analysis purposes.
PHARMACEUTICAL COMPOSITION, PRODUCT AND TREATMENT METHOD FOR A COGNITIVE DISORDER AND USES OF AN ACETILCOLINESTERASE INHIBITOR AND A 5- HT6 ANTAGONIST IN THE MANUFACTURE OF A MEDICINAL PRODUCT FOR THE TREATMENT OF A COGNITIVE DISORDER
Aryl-isoxasol-imidazole derived compounds; preparation procedure; pharmaceutical composition containing them; and use in the preparation of useful drugs in the treatment of cognitive disorders and Alzheimer's-related diseases.
SUBSTITUTED DERIVATIVES OF 7-CHLORINE-3H-IMIDAZOL- (4,5-B) PIRIDINE, PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM, PROCESSES FOR THE PREPARATION OF THE SAME AND APPLICATIONS